Australia's Mesoblast gains as quarterly loss narrows
** Shares of Mesoblast Ltd MSB.AX jump as much as 6.7% to
A$1.11, their biggest intraday pct gain since May 3
** The biotech co posts loss after tax of $18.6 mln for the
quarter ended March 31, compared with loss of $21.3 mln posted a
year earlier
** MSB says total revenue fell to $1.9 mln from $2 mln
** Stock up 19.5% YTD, as of last close
(Reporting by Harish Sridharan in Bengaluru)
((harish.sridharan@thomsonreuters.com))
Recent news on Mesoblast
See all newsBrief: Mesoblast William Burns To Retire From Board At 2026 AGM
Brief: Mesoblast Says Q1 Net Revenues Up 44%
Australia's Mesoblast hits one-month high on upbeat quarterly update
Australia's Mesoblast drops as Bell Potter cuts target price after key drug misses sales view
Brief: Mesoblast Says FDA Approves New Potency Assay For Commercial Ryoncil